HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A first case report of using chimeric antigen receptor T-cell immunotherapy to treat high-risk smoldering multiple myeloma.

AuthorsYang Liu, Wenbing Duan, Xiaojun Huang, Jin Lu
JournalJournal of translational internal medicine (J Transl Int Med) Vol. 11 Issue 3 Pg. 294-296 (Sep 2023) ISSN: 2450-131X [Print] Poland
PMID37662884 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: